10-K Filing

PRIVIA HEALTH GROUP, INC. CIK: 1759655 FY 2023

Filing Information

Form Type	10-K
Accession Number	`0001759655-24-000022`
Period End Date	20231231
Filing Date	20240227
Fiscal Year	2023
Fiscal Period	FY
XBRL Instance	prva-20231231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 67 Income Statement 54 Cash Flow Statement 95 Stockholders Equity 27

Balance Sheet 67 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$389.51M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$347.99M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	114.69M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	118.22M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$189.60M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	118.22M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	114.69M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$290.77M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$14.37M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$20.52M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$551.96M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$700.80M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.39M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.33M	USD	Point-in-time
Right-of-use asset	`OperatingLeaseRightOfUseAsset`	$8.09M	USD	Point-in-time
Right-of-use asset	`OperatingLeaseRightOfUseAsset`	$6.61M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$57.39M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$107.63M	USD	Point-in-time
Goodwill	`Goodwill`	$126.94M	USD	Point-in-time
Goodwill	`Goodwill`	$138.75M	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	$40.37M	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	$35.20M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$4.68M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$8.58M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$240.85M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$299.10M	USD	Point-in-time
Total assets	`Assets`	$792.81M	USD	Point-in-time
Total assets	`Assets`	$999.90M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$52.84M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$57.83M	USD	Point-in-time
Provider liability	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$208.42M	USD	Point-in-time
Provider liability	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$326.08M	USD	Point-in-time
Operating lease liabilities, current	`OperatingLeaseLiabilityCurrent`	$3.04M	USD	Point-in-time
Operating lease liabilities, current	`OperatingLeaseLiabilityCurrent`	$3.01M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$264.27M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$386.95M	USD	Point-in-time
Operating lease liabilities, non-current	`OperatingLeaseLiabilityNoncurrent`	$8.49M	USD	Point-in-time
Operating lease liabilities, non-current	`OperatingLeaseLiabilityNoncurrent`	$5.25M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$313.00K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.00M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$5.56M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$9.49M	USD	Point-in-time
Total liabilities	`Liabilities`	$273.76M	USD	Point-in-time
Total liabilities	`Liabilities`	$392.51M	USD	Point-in-time
Commitments and contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value, 1,000,000,000 and 1,000,000,000 shares authorized; 118,216,979 and 114,690,808 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively	`CommonStockValue`	$1.18M	USD	Point-in-time
Common stock, $0.01 par value, 1,000,000,000 and 1,000,000,000 shares authorized; 118,216,979 and 114,690,808 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively	`CommonStockValue`	$1.15M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$753.87M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$714.64M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-193.61M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-216.69M	USD	Point-in-time
Total Privia Health Group, Inc. stockholders equity	`StockholdersEquity`	$561.44M	USD	Point-in-time
Total Privia Health Group, Inc. stockholders equity	`StockholdersEquity`	$499.09M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$19.95M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$45.95M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$607.39M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$143.65M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$450.18M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$519.05M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$999.90M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$792.81M	USD	Point-in-time

Income Statement 54 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.36B	USD	Annual
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.66B	USD	Annual
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$966.22M	USD	Annual
Provider expense	`LiabilityForFuturePolicyBenefitsPeriodExpense`	$727.83M	USD	Annual
Provider expense	`LiabilityForFuturePolicyBenefitsPeriodExpense`	$1.30B	USD	Annual
Provider expense	`LiabilityForFuturePolicyBenefitsPeriodExpense`	$1.05B	USD	Annual
Cost of platform	`CostOfPlatform`	$197.66M	USD	Annual
Cost of platform	`CostOfPlatform`	$170.84M	USD	Annual
Cost of platform	`CostOfPlatform`	$174.73M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$19.74M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$22.75M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$24.73M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$255.88M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$129.59M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$109.59M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.57M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$6.53M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.46M	USD	Annual
Total operating expenses	`OperatingExpenses`	$1.38B	USD	Annual
Total operating expenses	`OperatingExpenses`	$1.18B	USD	Annual
Total operating expenses	`OperatingExpenses`	$1.64B	USD	Annual
Operating income (loss)	`OperatingIncomeLoss`	$20.65M	USD	Annual
Operating income (loss)	`OperatingIncomeLoss`	$-217.44M	USD	Annual
Operating income (loss)	`OperatingIncomeLoss`	$-19.12M	USD	Annual
Interest (income) expense, net	`InterestIncomeExpenseNet`	$542.00K	USD	Annual
Interest (income) expense, net	`InterestIncomeExpenseNet`	$8.37M	USD	Annual
Interest (income) expense, net	`InterestIncomeExpenseNet`	$-1.07M	USD	Annual
Income (loss) before provision for (benefit from) income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$29.02M	USD	Annual
Income (loss) before provision for (benefit from) income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-218.51M	USD	Annual
Income (loss) before provision for (benefit from) income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-18.58M	USD	Annual
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$7.99M	USD	Annual
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$-6.52M	USD	Annual
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$-27.86M	USD	Annual
Net income (loss)	`ProfitLoss`	$-190.65M	USD	Annual
Net income (loss)	`ProfitLoss`	$-12.06M	USD	Annual
Net income (loss)	`ProfitLoss`	$21.03M	USD	Annual
Less: Loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.42M	USD	Annual
Less: Loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-3.48M	USD	Annual
Less: Loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.05M	USD	Annual
Net income (loss) income attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$23.08M	USD	Annual
Net income (loss) income attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$-8.59M	USD	Annual
Net income (loss) income attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$-188.23M	USD	Annual
Net income (loss) income per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$0.20	USD	Annual
Net income (loss) income per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$-0.08	USD	Annual
Net income (loss) income per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$-1.83	USD	Annual
Net income (loss) income per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.08	USD	Annual
Net income (loss) income per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.83	USD	Annual
Net income (loss) income per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.19	USD	Annual
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	110.70M	shares	Annual
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	116.73M	shares	Annual
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	102.95M	shares	Annual
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	110.70M	shares	Annual
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	102.95M	shares	Annual
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	124.69M	shares	Annual

Cash Flow Statement 95 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-190.65M	USD	Annual
Net income (loss)	`ProfitLoss`	$-12.06M	USD	Annual
Net income (loss)	`ProfitLoss`	$21.03M	USD	Annual
Depreciation	`Depreciation`	$1.22M	USD	Annual
Depreciation	`Depreciation`	$1.15M	USD	Annual
Depreciation	`Depreciation`	$1.17M	USD	Annual
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$3.35M	USD	Annual
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$1.31M	USD	Annual
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$5.36M	USD	Annual
Amortization of debt issuance costs	`AmortizationAdditionOfDebtIssuanceCosts`	-	USD	Annual
Amortization of debt issuance costs	`AmortizationAdditionOfDebtIssuanceCosts`	$687.00K	USD	Annual
Amortization of debt issuance costs	`AmortizationAdditionOfDebtIssuanceCosts`	$157.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$253.53M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$37.10M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$67.36M	USD	Annual
Debt Issuance costs Amortization	`AmortizationOfFinancingCosts`	-	USD	Annual
Debt Issuance costs Amortization	`AmortizationOfFinancingCosts`	-	USD	Annual
Debt Issuance costs Amortization	`AmortizationOfFinancingCosts`	-	USD	Annual
Deferred tax expense (benefit)	`DeferredIncomeTaxExpenseBenefit`	$-7.00M	USD	Annual
Deferred tax expense (benefit)	`DeferredIncomeTaxExpenseBenefit`	$-28.41M	USD	Annual
Deferred tax expense (benefit)	`DeferredIncomeTaxExpenseBenefit`	$7.46M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$72.20M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$96.88M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$14.64M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$6.16M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$5.67M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.27M	USD	Annual
Other non-current assets and right-of-use asset	`IncreaseDecreaseInOtherNoncurrentAssets`	$9.68M	USD	Annual
Other non-current assets and right-of-use asset	`IncreaseDecreaseInOtherNoncurrentAssets`	$2.42M	USD	Annual
Other non-current assets and right-of-use asset	`IncreaseDecreaseInOtherNoncurrentAssets`	$-1.38M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayable`	$4.99M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayable`	$6.85M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayable`	$1.26M	USD	Annual
Provider liability	`IncreaseDecreasePhysicianAndPracticeLiability`	$33.90M	USD	Annual
Provider liability	`IncreaseDecreasePhysicianAndPracticeLiability`	$113.37M	USD	Annual
Provider liability	`IncreaseDecreasePhysicianAndPracticeLiability`	$67.72M	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-3.21M	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-2.43M	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$13.94M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-1.03M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-5.54M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-2.00M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$55.06M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$47.20M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$80.78M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$113.00K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$547.00K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$104.00K	USD	Annual
Business acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Business acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$42.86M	USD	Annual
Business acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$32.23M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-32.77M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-104.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-42.97M	USD	Annual
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	$223.69M	USD	Annual
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	Annual
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	Annual
Payments of underwriting fees, net of discounts and offering costs	`PaymentsOfStockIssuanceCosts`	-	USD	Annual
Payments of underwriting fees, net of discounts and offering costs	`PaymentsOfStockIssuanceCosts`	$12.69M	USD	Annual
Payments of underwriting fees, net of discounts and offering costs	`PaymentsOfStockIssuanceCosts`	-	USD	Annual
Repurchase of non-controlling interest	`PaymentsToMinorityShareholders`	-	USD	Annual
Repurchase of non-controlling interest	`PaymentsToMinorityShareholders`	$5.69M	USD	Annual
Repurchase of non-controlling interest	`PaymentsToMinorityShareholders`	-	USD	Annual
Proceeds from non-controlling interest	`ProceedsFromMinorityShareholders`	-	USD	Annual
Proceeds from non-controlling interest	`ProceedsFromMinorityShareholders`	$659.00K	USD	Annual
Proceeds from non-controlling interest	`ProceedsFromMinorityShareholders`	$125.00K	USD	Annual
Repayment of note payable	`RepaymentsOfNotesPayable`	$875.00K	USD	Annual
Repayment of note payable	`RepaymentsOfNotesPayable`	$33.25M	USD	Annual
Repayment of note payable	`RepaymentsOfNotesPayable`	-	USD	Annual
Proceeds from exercised stock options	`ProceedsFromStockOptionsExercised`	$3.83M	USD	Annual
Proceeds from exercised stock options	`ProceedsFromStockOptionsExercised`	$8.74M	USD	Annual
Proceeds from exercised stock options	`ProceedsFromStockOptionsExercised`	$13.45M	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$287.00K	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.71M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-19.68M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$213.66M	USD	Annual
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$235.94M	USD	Annual
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$41.52M	USD	Annual
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$27.41M	USD	Annual
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$389.51M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$320.58M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$347.99M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$84.63M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$389.51M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$320.58M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$347.99M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$84.63M	USD	Point-in-time
Interest paid	`InterestPaidNet`	$40.00K	USD	Annual
Interest paid	`InterestPaidNet`	$713.00K	USD	Annual
Interest paid	`InterestPaidNet`	$888.00K	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	$504.00K	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	$1.04M	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	$307.00K	USD	Annual

Stockholders Equity 27 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance (in shares)	`CommonStockSharesOutstanding`	118.22M	shares	Point-in-time
Beginning Balance (in shares)	`CommonStockSharesOutstanding`	114.69M	shares	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$607.39M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$143.65M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$450.18M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$519.05M	USD	Point-in-time
Issuance of common stock upon closing of initial public offering	`StockIssuedDuringPeriodValueNewIssues`	$210.99M	USD	Annual
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueShareBasedCompensation`	$8.74M	USD	Annual
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueShareBasedCompensation`	$13.45M	USD	Annual
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.83M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$67.36M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$253.53M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$37.10M	USD	Annual
Repurchase of non-controlling interest	`MinorityInterestDecreaseFromRedemptions`	$5.69M	USD	Annual
Contributed non-controlling interest	`NoncontrollingInterestIncreaseFromBusinessCombination`	$24.87M	USD	Annual
Contributed non-controlling interest	`NoncontrollingInterestIncreaseFromBusinessCombination`	$125.00K	USD	Annual
Contributed non-controlling interest	`NoncontrollingInterestIncreaseFromBusinessCombination`	$28.82M	USD	Annual
Tax effect related to purchase of non-controlling interest	`AdjustmentToAdditionalPaidInCapitalTaxEffectRelatedToPurchaseOfNonControllingInterest`	$2.30M	USD	Annual
Net income (loss)	`ProfitLoss`	$-190.65M	USD	Annual
Net income (loss)	`ProfitLoss`	$-12.06M	USD	Annual
Net income (loss)	`ProfitLoss`	$21.03M	USD	Annual
Ending Balance (in shares)	`CommonStockSharesOutstanding`	118.22M	shares	Point-in-time
Ending Balance (in shares)	`CommonStockSharesOutstanding`	114.69M	shares	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$607.39M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$143.65M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$450.18M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$519.05M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.